reference/18985186

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18985186

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	11671
issn	1944-8252 1944-8244
issueIdentifier	10
pageRange	11657-11671
publicationName	ACS Applied Materials & Interfaces
startingPage	11657
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_70abf1ffb7b93a873efff855532f08ab http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a71960533e57bbfecb38e66869a95032 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
bibliographicCitation	Meng L, Wang C, Lu Y, Sheng G, Yang L, Wu Z, Xu H, Han C, Lu Y, Han F. Targeted Regulation of Blood-Brain Barrier for Enhanced Therapeutic Efficiency of Hypoxia-Modifier Nanoparticles and Immune Checkpoint Blockade Antibodies for Glioblastoma. ACS Appl Mater Interfaces. 2021 Mar 17;13(10):11657–71. doi: 10.1021/acsami.1c00347. PMID: 33684289.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_21192cd27628f0935d82e9d314c63f96 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_46164692e50084bfdcdf55aebe1eeca7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_16fddc3dd79dd33a35b6d857030be8c5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3ce6f9f7be7a5457e93494f381209a64 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d12821334342b3c468783d7f38c98304 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_58e11e8d754ed4100e07cd571a7f0063 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1ac1af91320407b625f2084edbbab844 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f749cfdca0d90dd1b6d4e4932dc98ecc http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7800-9852 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fcc8d9493ba118ce5dd29ffaf8153cce
date	2021-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1021/acsami.1c00347 https://pubmed.ncbi.nlm.nih.gov/33684289
isPartOf	https://portal.issn.org/resource/ISSN/1944-8252 https://portal.issn.org/resource/ISSN/1944-8244 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/36564
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Targeted Regulation of Blood–Brain Barrier for Enhanced Therapeutic Efficiency of Hypoxia-Modifier Nanoparticles and Immune Checkpoint Blockade Antibodies for Glioblastoma
discusses	http://id.nlm.nih.gov/mesh/M000675754 http://id.nlm.nih.gov/mesh/M0545332
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D001932Q000188 http://id.nlm.nih.gov/mesh/D058906Q000627 http://id.nlm.nih.gov/mesh/D053758Q000627 http://id.nlm.nih.gov/mesh/D000082082Q000627 http://id.nlm.nih.gov/mesh/D001812Q000187 http://id.nlm.nih.gov/mesh/D005909Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D053758Q000008 http://id.nlm.nih.gov/mesh/D008807 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005909Q000378 http://id.nlm.nih.gov/mesh/D001932Q000378 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D058906Q000008 http://id.nlm.nih.gov/mesh/D000072258Q000187 http://id.nlm.nih.gov/mesh/D016503 http://id.nlm.nih.gov/mesh/D001812Q000378
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6914 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6393 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5394 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14801 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7838 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b0f84b2afa6531434f6d5376b614216c http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7099

Total number of triples: 60.